Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05589948 · ClinicalTrials.gov registry record · NA
Radicle Calm 1: A Study of Health and Wellness Products on Feelings of Anxiety, Stress and Other Health Outcomes
A NA study, sponsored by Radicle Science.
- Completed
- Registry status
- NA
- Development phase
- 1,211
- Enrollment target
NCT05589948: Completed NA study, sponsored by Radicle Science.
NCT05589948 is a NA study that has completed, run by Radicle Science. The registered enrollment target is 1,211 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (14% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05589948, a NA study, has completed, sponsored by Radicle Science.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,211 participants
- Enrollment target
Study Summary
A randomized, blinded, placebo-controlled, direct-to-consumer study assessing the impact of health and wellness products on feelings of anxiety, stress and other health outcomes
Primary Outcome
Mean difference in feelings of anxiety score as assessed by Patient Reported Outcome Measurement System (PROMIS) Anxiety 8A (scale 8-40; where lower scores correspond to less feelings of anxiety)
Interventions
- DIETARY_SUPPLEMENT Radicle Calm Study Placebo Control 1
- DIETARY_SUPPLEMENT Radicle Calm Study Placebo Control 2
- DIETARY_SUPPLEMENT Radicle Calm Study Active Product 1.1
- DIETARY_SUPPLEMENT Radicle Calm Study Active Product 2.1
- DIETARY_SUPPLEMENT Radicle Calm Study Active Product 2.2
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,211 participants |
| Start Date | 2022-10-10 |
| Est. Completion | 2023-08-15 |
| Phase | NA |
What the finished NCT05589948 record still lists
NCT05589948 is an interventional study that assigns participants to a tested intervention. Its 1,211 participants enrollment target places it among the larger protocols in the corpus, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (14% lower).
The record links to 0 conditions, and to 5 interventions - of which Radicle Calm Study Placebo Control 1 is the first listed.
NCT05589948 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05589948 about?
NCT05589948 is a clinical study titled "Radicle Calm 1: A Study of Health and Wellness Products on Feelings of Anxiety, Stress and Other Health Outcomes". A randomized, blinded, placebo-controlled, direct-to-consumer study assessing the impact of health and wellness products on feelings of anxiety, stress and other health outcomes
What is the current status of trial NCT05589948?
This trial is currently completed. It is a NA study. The enrollment target is 1,211 participants. The study started on 2022-10-10. Estimated completion is 2023-08-15.
What interventions are being tested in trial NCT05589948?
The interventions under investigation include: Radicle Calm Study Placebo Control 1 (DIETARY_SUPPLEMENT), Radicle Calm Study Placebo Control 2 (DIETARY_SUPPLEMENT), Radicle Calm Study Active Product 1.1 (DIETARY_SUPPLEMENT), Radicle Calm Study Active Product 2.1 (DIETARY_SUPPLEMENT), Radicle Calm Study Active Product 2.2 (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT05589948?
This trial is sponsored by Radicle Science, which has 55 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05589948's enrollment target sits among peer trials
1,211 83rd of 2000 higher than 1,918 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04267848 · 1,210 participants · Phase 3
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
- NCT05946213 · 1,209 participants · Phase 3
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
- NCT05827016 · 1,216 participants · Phase 3
A Study to Compare Iberdomide Maintenance Versus Lenalidomide Maintenance Therapy Following Autologous Stem Cell Transplant in Participants With Newly Diagnosed Multiple Myeloma
- NCT06143956 · 1,217 participants · Phase 2
A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI